|

IKS03 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Iksuda Therapeutics Ltd.1

Indications

  • B Cell Lymphoma1
  • Mantle Cell Lymphoma1
  • B-Cell Non-Hodgkin Lymphoma1
  • Diffuse Large B-Cell Lymphoma1
  • Follicular Lymphoma1

Baltimore, Maryland1 trial

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

University of Maryland Baltimore

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.